Sep 30, 2026 8:00 am EDT bioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL
Sep 22, 2026 8:00 am EDT bioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference
Sep 17, 2026 8:00 am EDT bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic
Sep 3, 2026 4:30 pm EDT bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 1, 2026 8:00 am EDT bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors
Aug 20, 2026 8:00 am EDT bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026
Aug 18, 2026 8:00 am EDT bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung
Aug 14, 2026 11:07 am EDT bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
Aug 13, 2026 9:07 am EDT bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
